These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Lane DM, McConathy WJ, Laughlin LO, Comp PC, von Albertini B, Gibson SM, Bricker LA, Kozlovskis P, Dorrier C. Am J Cardiol; 1993 Apr 01; 71(10):816-22. PubMed ID: 8456760 [Abstract] [Full Text] [Related]
3. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO. Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498 [Abstract] [Full Text] [Related]
4. Low-density lipoprotein apheresis: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2007 Jun 01; 7(5):1-101. PubMed ID: 23074505 [Abstract] [Full Text] [Related]
5. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Kroon AA, van't Hof MA, Demacker PN, Stalenhoef AF. Atherosclerosis; 2000 Oct 01; 152(2):519-26. PubMed ID: 10998482 [Abstract] [Full Text] [Related]
7. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Berger GM, Firth JC, Jacobs P, Wood L, Marais AD, Horak A. Am J Med; 1990 Feb 01; 88(2):94-100. PubMed ID: 2105647 [Abstract] [Full Text] [Related]
8. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D. Z Kardiol; 2003 Feb 01; 92(Suppl 3):III42-7. PubMed ID: 14663601 [Abstract] [Full Text] [Related]
10. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases]. Mo JK, Li YX, Lei D, Wu DH. Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar 01; 22(3):278-9. PubMed ID: 12390791 [Abstract] [Full Text] [Related]
11. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures. van Buuren F, Kreickmann S, Horstkotte D, Kottmann T, Mellwig KP. Clin Res Cardiol Suppl; 2012 Jun 01; 7(Suppl 1):24-30. PubMed ID: 22528135 [Abstract] [Full Text] [Related]
12. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia. Park JW, Merz M, Braun P. Atherosclerosis; 1998 Aug 01; 139(2):401-9. PubMed ID: 9712348 [Abstract] [Full Text] [Related]
13. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study. Wendler T, Schilling R, Lennertz A, Sodemann K, Kleophas W, Messner H, Riechers G, Wagner J, Keller C, Bosch T. J Clin Apher; 2003 Aug 01; 18(4):157-66. PubMed ID: 14699591 [Abstract] [Full Text] [Related]
14. Efficacy of different low-density lipoprotein apheresis methods. Parhofer KG, Geiss HC, Schwandt P. Ther Apher; 2000 Oct 01; 4(5):382-5. PubMed ID: 11111821 [Abstract] [Full Text] [Related]